Aaron Sulkes

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Drug Therapy 75%
3. Neoplasms 54%
4. Radiotherapy 48%
5. Fluorouracil 45%
6. Doxorubicin 42%
7. Israel 38%
8. Survival 36%
9. Colorectal Neoplasms 32%
10. Stomach Neoplasms 32%
11. Cisplatin 31%
12. Therapeutics 28%
13. Melanoma 27%
14. Merkel Cell Carcinoma 26%
15. Rectal Neoplasms 25%
16. Cyclophosphamide 24%
17. Neoplasm Metastasis 23%
18. Carcinoma 23%
19. Recurrence 22%
20. Docetaxel 21%
21. Combination Drug Therapy 20%
22. Capecitabine 19%
23. Methotrexate 18%
24. Radiation 18%
25. Leucovorin 16%
26. Liposomes 15%
27. Disease-Free Survival 15%
28. Jews 14%
29. Adjuvant Chemotherapy 14%
30. Dacarbazine 14%
31. Esophageal Neoplasms 13%
32. Kaposi's Sarcoma 13%
33. Vinblastine 13%
34. Clinical Studies 13%
35. Chemoradiotherapy 12%
36. Mutation 12%
37. Airway Obstruction 12%
38. Survival Rate 12%
39. Transcobalamins 11%
40. Aminoglutethimide 11%
41. Brachytherapy 11%
42. Prospective Studies 11%
43. Second Primary Neoplasms 10%
44. Pharmaceutical Preparations 10%
45. Trastuzumab 10%
46. Pharmacokinetics 10%
47. Squamous Cell Carcinoma 10%
48. Androgens 9%
49. Appointments and Schedules 9%
50. Incidence 9%